Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55+
SponsorChang Gung Memorial Hospital
About this trial
This study aims to evaluate the effects of endogenous gamma non-flickering light stimulation on resting-state EEG rhythms and cognitive function in cognitively healthy older adults. Specifically, it will assess the immediate and long-term effects of this stimulation on brainwave activity and cognitive performance. The study will explore the potential of gamma light stimulation as a non-pharmacological intervention for cognitive decline in aging populations.
Eligibility criteria
Qualifiers
1. Age over 55 years old.
2. The Cognitive Abilities Screening Instrument (CASI) score is within normal ranges adjusted for age and education.
3. Participants have no history of severe neurological or psychiatric disorders (such as stroke, epilepsy, depression, migraine, etc.) that could affect cognitive function.
4. Participants have not used drugs that may affect cognitive function (e.g., benzodiazepines, anticholinergic medications, etc.).
Disqualifiers
1. Participants enrolled in any cognitive enhancement study within the past two months.
2. Participants with a history of disease that could affect cognitive function (e.g., cancer, autoimmune diseases, etc.).
3. Pregnant, or planning to become pregnant.
Trial design
Treatments tested in this trial
- Gamma Wave Stimulation Table Lamp (Aleddra, Inc., USA)
Treatment groups
52 Participants
are divided into 2 treatment groupsSponsors and collaborators
Chang Gung Memorial Hospital
Lead sponsor
Aleddra, Inc.
Collaborator
Source ClinicalTrials.gov